Your trusted destination for CME, CPD & Medical Education across the Middle East.
Sidra Medicine
Dr. Khalid A. Fakhro is an internationally recognized human geneticist, genomic medicine researcher, and academic leader based in Qatar. He serves as Chief Research Officer and Chair of the Precision Medicine Program at Sidra Medicine, where he leads research initiatives focused on human genetics, genomic medicine, rare diseases, and personalized healthcare.
Dr. Fakhro's academic background combines molecular biology, human genetics, and translational medical research. He graduated with honors from the University of Chicago, majoring in Biological Sciences with a specialization in Cellular Biology and Molecular Genetics. He subsequently earned his PhD in Human Genetics from Yale University, where he participated in the highly selective Howard Hughes Medical Institute (HHMI) Translational Medicine Scholars program. This training helped establish his focus on translating discoveries from laboratory research into practical clinical applications.
Before joining Sidra Medicine in July 2014, Dr. Fakhro was affiliated with the Department of Genetic Medicine at Weill Cornell Medicine in Qatar. At Sidra, he initially joined as a Principal Investigator and later led the Human Genetics Department. In 2018, he became the inaugural Director of the Precision Medicine Program, helping establish genomic research and personalized medicine as important components of the institution's clinical and academic activities.
His research focuses on identifying genetic variants responsible for rare and complex disorders, particularly in children and families across Qatar and the wider Middle East. His laboratory has sequenced thousands of genomes from patients and volunteers, contributing to gene discovery, population genomics, and research into the genetic architecture of Arab populations, which remain underrepresented in international genomic databases.
Dr. Fakhro has also played an important role in advancing genomic research in autism, diabetes, cardiovascular conditions, fertility disorders, and other complex diseases. His work combines whole-genome sequencing, bioinformatics, metabolomics, transcriptomics, and other advanced technologies to improve disease understanding and support the development of more individualized approaches to diagnosis and treatment.

Maarefah Management
Maarefah Management